Dimers of Aβ (amyloid β-protein) are believed to play an important role in Alzheimer's disease. In the absence of sufficient brain-derived dimers, we studied one of the only possible dimers that could be produced in vivo, [Aβ] DiY (dityrosine cross-linked Aβ). For comparison, we used the Aβ monomer and a design dimer cross-linked by replacement of Ser 26 with cystine [AβS26C] 2 . We showed that similar to monomers, unaggregated dimers lack appreciable structure and fail to alter long-term potentiation. Importantly, dimers exhibit subtly different structural propensities from monomers and each other, and can self-associate to form larger assemblies. Although [Aβ] DiY and [AβS26C] 2 have distinct aggregation pathways, they both populate bioactive soluble assemblies for longer durations than Aβ monomers. Our results indicate that the link between Aβ dimers and Alzheimer's disease results from the ability of dimers to further assemble and form synaptotoxic assemblies that persist for long periods of time.
INTRODUCTION
AD (Alzheimer's disease) represents a personal and societal tragedy of enormous proportions [1] . Strong genetic evidence links the APP (amyloid precursor protein) and its proteolytic derivatives to AD [2] . A leading hypothesis proposes that a small amphipathic fragment of APP, the Aβ (amyloid β-protein), selfassociates to form assemblies loosely referred to as oligomers, and that these trigger a complex pathogenic sequence of events that culminate in dementia [3] [4] [5] [6] . Several mutations within the Aβ sequence cause early-onset AD and are believed to increase the formation of toxic Aβ assemblies (reviewed in [7] ). However, such mutations are very rare and most cases of AD occur in individuals with the normal Aβ sequence. Why wild-type Aβ folds to form toxic assemblies is unclear and may involve both intrinsic and extrinsic factors. One possibility is that certain posttranslational modifications of Aβ may arise in some individuals and that these lead to sufficiently high levels of toxic Aβ assemblies so as to precipitate sporadic AD.
Although the forms of Aβ that mediate memory impairment and the toxic pathways activated by Aβ remain unresolved, numerous studies have shown that non-fibrillar water-soluble Aβ from a variety of sources are potent synaptotoxins [8] [9] [10] . Post-mortem studies indicate that elevated levels of water-soluble Aβ are specific for AD [11] [12] [13] [14] and in vitro studies show that such material robustly inhibits LTP (long-term potentiation), facilitates LTD (long-term depression) and induces tau hyperphosphorylation and neuritic degeneration [10, 15, 16] . Aβ from bioactive AD brain extracts migrates on SDS/PAGE (16 % gel) as broad bands centred at ∼4 and ∼8 kDa. In an earlier study, we fractionated aqueous extract from an AD brain using SEC (size-exclusion chromatography) and Aβ eluted in fractions consistent with monomer, dimer and high-molecular-mass species of undefined size [10] . Testing of each fraction revealed that the dimer fraction, but not the monomer fraction, blocked LTP [10] . However, since fractions were frozen, freeze-dried and reconstituted in artificial cerebrospinal fluid, and then used in LTP experiments [10] , it is unclear whether the activity attributed to dimers was mediated by dimers, or assemblies formed by dimers. Indeed, we have demonstrated that the plasticity-disrupting activity originally attributed to a covalent dimer [10] was in fact mediated by soluble aggregates formed from this dimer [17] . Owing to the technical difficulties in studying freshly size-isolated brain dimers, it remains unclear whether native dimers have direct synaptotoxic activity or whether they gain activity by forming larger structures. How brain dimers form and interactions that govern the association of component monomers remains enigmatic. In the absence of sufficient highly pure brain-derived Aβ dimers, we and others have used synthetic dimers to gain insight into the natural species. In earlier studies, Aβ(1-40) containing a cysteine residue in place of Ser 26 was used to produce disulfide cross-linked dimers [Aβ(1-40)S26C] 2 . Such dimers rapidly aggregated to form protofibrils, and similar to brainderived Aβ, potently inhibited LTP [10, 17] , facilitated aberrant phosphorylation of tau and induced neuritic degeneration [16] . Aβ dimers produced by introduction of the cystine residue at either the N-or C-terminus of Aβ [e.g. Aβ(1-40)A2C and Aβ -GGGC] also rapidly aggregated to form kinetically trapped protofibrils [18] . Similarly, dimers formed by alkyl crosslinking of alanine residues introduced at position 10 aggregated without a detectable time lag [19] . Although, in Nature, mutations that introduce cysteine residues into the Aβ sequence or promote alkylizing cross-links have not been found, certain posttranslational modifications have the potential to covalently link two (or more) Aβ monomers. One possibility would involve the phenolic coupling of tyrosine residues. DiY (dityrosine) crosslinking can result from an increase in oxidative stress and a number of different tyrosine-containing proteins are known to form DiY [20] . Importantly, DiY cross-linking is increased in the AD brain [21] and a recent immuno-EM report detected DiY in amyloid plaques that co-stained for Aβ [22] . Moreover, in test tube experiments, Aβ can be readily induced to form [Aβ] DiY (dityrosine cross-linked Aβ) [22] [23] [24] [25] .
In the present study, we sought to investigate the structures of wild-type Aβ monomer, [ 13 Cα, 1 Hα cross-peak differences between the dimers and wild-type monomer mainly located around the sites of covalent cross-linking. However, using chemical shift differences to estimate the propensity for secondary structure, we found that [Aβ(M1-40)S26C] 2 has a slightly greater propensity to form β-sheet structure than wild-type monomer. On the other hand, [Aβ(M1-40)] DiY displays a slight increase in helicity throughout the Aβ molecule, except at the extreme C-terminus. In addition, the aggregation propensity and products formed by the three peptides are very different.
Aggregation of monomer is characterized by a short, but discernible, lag phase after which aggregates are formed more rapidly, producing bundles of laterally associated amyloid fibrils, whereas [AβS26C] 2 aggregates without a time lag and forms protofibrils. The behaviour of [Aβ] DiY is distinct from both the other two peptides, with [Aβ] DiY aggregating very slowly to form long smooth individual amyloid fibrils. Despite the fact that these peptides aggregate at very different rates to form different endproducts, all three can form neuroplasticity-disrupting assemblies. Thus it appears that the synaptotoxic activity of aggregate intermediates is not readily related to the starting structure of Aβ monomers or dimers, or to the end-stage aggregates they form, but better relates to the size of intermediates. The finding that dimers populated aggregation intermediates for prolonged periods (relative to those formed by monomer) suggests that dimers may be the cause of the synaptic dysfunction that characterizes AD.
MATERIALS AND METHODS

Reagents
Unless otherwise stated, all chemicals and reagents were purchased from Sigma-Aldrich and were of the highest purity available. Synthetic peptides, Aβ and Aβ(1-40)S26C, were synthesized and purified using reverse-phase HPLC by Dr James I. Elliott at Yale University (New Haven, CT, U.S.A.). Peptide mass and purity (>99 %) were confirmed by electrospray/ion trap MS, reverse-phase HPLC and SDS/PAGE with silver staining.
Bacterial expression of Aβ peptides
Recombinant Aβ(M1-40) and Aβ(M1-40)S26C were expressed and purified essentially as described previously [27] . pET vectors containing a synthetic gene beginning with AUG (start codon, methionine) followed by the sequence for both Aβ(1-40) wildtype and Ser 26 substituted for cysteine residue, Aβ(1-40)S26C, were used to transform Escherichia coli BL21* DE3 pLysS cells (Promega Biosciences). Cells with the appropriate vector were grown on LB agar plates containing 50 μg/ml ampicillin and 38 μg/ml chloramphenicol. A single colony was transferred to 50 ml of LB medium (containing antibiotics) and incubated for 12 h at 37
• C in an orbital shaker-incubator at 120 rev./min. The starter culture was used to inoculate (at 100-fold dilution) 400 ml aliquots of LB medium and incubated at 37
• C with shaking at 120 rev./min. Cell density was measured every 45 min and when attenuance at 600 nm reached ∼0.6, peptide expression was induced by the addition of IPTG. Bacterial cells were collected by centrifugation and pelleted from a 400 ml culture snap-frozen in 25 ml of 10 mM Tris/HCl, pH 8.5, containing 1 mM EDTA (buffer A). Pellets were thawed at room temperature and sonicated. The sonicated suspension was collected by centrifugation at 18 000 g and the supernatant discarded. The pellet was resuspended in 25 ml of buffer A, sonicated and centrifuged as above. Following three rounds of sonication in buffer A, inclusion bodies containing Aβ were solubilized in 15 ml of 8 M urea/buffer A with sonication and cleared of insoluble debris by centrifugation.
Purification of recombinant Aβ peptides
The inclusion bodies solution was diluted in a ratio of 1:4 with buffer A and incubated at room temperature with Whatman DE23 anion-exchange resin and gently agitated for 30 min. The DE23 resin was isolated using a vacuum filter and washed with buffer A containing 25 mM NaCl. Aβ was eluted in buffer A containing 125 mM NaCl. Aβ-containing fractions were pooled, transferred to a 3 kDa MWCO (molecular-mass cut-off) dialysis sac (Thermo Scientific) and extensively dialysed against 10 mM ammonium bicarbonate, pH 8.5, and the dialysate freeze-dried. Semi-purified bacterial extract (25 mg) was dissolved in 3 ml of 7 M guanidine hydrochloride in 50 mM Tris/HCl, pH 8.5, containing 5 mM EDTA in the presence or absence of 2.5 % 2-mercaptoethanol and Aβ further purified on a Superdex 75 16/60 column (GE Healthcare) eluted in 50 mM ammonium bicarbonate, pH 8.5, at 0.8 ml/min. Peak fractions were pooled and the peptide concentration was determined by molar absorption coefficient ε 275 Figure S2 at http://www.biochemj.org/bj/461/bj4610413add.htm). Aliquots of peptide ranging from 0.5 to 5 mg were freeze-dried. All peptides were at least 99.9 % pure as determined by SDS/PAGE or silver staining and reverse-phase HPLC. Peptide mass was confirmed by MALDI-TOF-MS.
Oxidative cross-linking of Aβ peptides
Aliquots (5 mg) of Aβ or Aβ(M1-40) were dissolved in 0.5 ml of 7 M guanidine hydrochloride and purified on a Superdex 75 10/300 column (GE Healthcare), and then eluted in 50 mM ammonium bicarbonate, pH 8.5. Peak fractions were collected and pooled, and peptide concentration determined by molar absorption coefficient ε 275 . The sample was then diluted to 40 μM and incubated at 37
• C overnight in the presence of 2.2 μM horseradish peroxidase (Thermo Scientific) and 250 μM H 2 O 2 [28] . Reduced AβS26C monomer was diluted to 40 μM and incubated at room temperature and bubbled with oxygen for 5 min every 24 h for 72 h [17] . Following crosslinking, the reaction mixtures were freeze-dried. Freeze-dried peptides were redissolved in 3 ml of 7 M guanidine hydrochloride and incubated overnight at room temperature and the Aβ dimer was isolated using a Superdex 75 16/60 column eluted in 50 mM ammonium bicarbonate. Peak fractions of dimer were pooled and their concentration determined by Figure S2 ).
ThT (thioflavin T) dye-binding assay
The peptide was dissolved in 7 M guanidine hydrochloride and incubated overnight at room temperature and used for SEC as described above. Aggregation was monitored using a continuous ThT-binding assay. Samples were diluted with a 100-fold ThT stock to 20 μM ThT and the highest stock concentration of Aβ peptide (40 μM-20 μM) and where appropriate this was diluted using SEC elution buffer containing ThT. Six 120 μl replicates of each Aβ concentration were transferred to a black flat bottom, 96-well polystyrene plate (Fisher Scientific). A blank (no peptide containing) sample was also prepared. The outer edge wells of the plate were filled with buffer. At zero time (t = 0), plates were analysed on a SpectraMax M2 microplate reader (Molecular Devices) with 5 s of shaking before readings (λ em = 435 nm and λ em = 485 nm). Plates were sealed with an adhesive cover and incubated at 37
• C with or without shaking at 700 rev./min in a WorTemp 56 incubator/shaker (3 mm orbit; Labnet International). Plates were removed from the incubator-shaker at regular intervals and the fluorescence was measured. Lag time is defined as the first of two consecutive time points showing a statistically significant increase (Student's t test) in fluorescence compared with the t = 0 reading; the rate of aggregation is given by the maximum slope of the linear phase of aggregation [29] .
In order to produce the t1 / 2 max and t max material used for LTP experiments, a preliminary experiment was conducted using 20 μM of each peptide as described above. The maximal fluorescence and the time taken to attain half maximal fluorescence were used to guide the subsequent experiment in which t1 / 2 max or t max samples were prepared. In the second phase of the experiment, peptide samples were isolated and prepared exactly as in the preliminary experiment, but this time, two replicates were incubated with ThT and four replicates without. Fluorescence was monitored for the samples containing ThT. When readings equal to the t1 / 2 max or t max values obtained in the preliminary experiment were reached, the samples without ThT were then collected, separated into aliquots and frozen. Monitoring of the samples containing ThT was continued until maximal aggregation was achieved.
Negative stain EM
Samples (10 μl) were applied to carbon-coated Formvar grids for 1 min and then cross-linked using 10 μl of 0.5 % gluteraldehyde. Grids were washed gently with Milli-Q water (Millipore), stained for 2 min with 2 % uranyl acetate (Electron Microscope Sciences) and blotted dry. Samples were prepared in duplicate and examined using a Tecnai G 2 Spirit BioTWIN electron microscope (FEI). EM grids were scanned in a serpentine fashion at ∼×12000, then regions of interest were examined at higher magnification and images captured with an AMT 2k CCD (charge-coupled-device) camera.
Animals and surgery
Experiments were carried out on urethane (1.5-1.6 g/kg of body mass via intraperitoneal injection)-anaesthetized male Wistar rats (250-300 g). The body temperature of the rats was maintained at 37-38
• C with a feedback-controlled heating blanket. The animal care and experimental protocol were approved by the Department of Health, Republic of Ireland.
Cannula and electrode implantation
A stainless-steel cannula (22 gauge, 0.7 mm outer diameter) was implanted above the right lateral ventricle (1 mm lateral to the midline, 0.5 mm posterior to the bregma and 4 mm below the surface of the dura). Intracerebroventricular injection was made via an internal cannula (28 gauge, 0.36 mm outer diameter). The solutions were injected at ∼1 μl per min (total volume 8 μl). Verification of the placement of cannula was performed post mortem by checking the spread of ink dye after intracerebroventricular injection. The dose of Aβ chosen for injection was based on initial pilot dose titration experiments and our previous results [30] . Twisted bipolar electrodes were constructed from Teflon-coated tungsten wires (62.5 μm inner core diameter, 75 μm external diameter). Field EPSPs (excitatory postsynaptic potentials) were recorded from the stratum radiatum in the CA1 area of the right hippocampus in response to stimulation of the ipsilateral Schaffer collateral-commissural pathway. Electrode implantation sites were identified using stereotaxic co-ordinates relative to the bregma, with the recording site located 3.4 mm posterior to bregma and 2.5 mm lateral to midline, and stimulating site 4.2 mm posterior to bregma and 3.8 mm lateral to midline. The final placement of electrodes was optimized by using electrophysiological criteria and confirmed via post-mortem analysis.
Electrophysiology and data analysis
Test EPSPs were evoked by square wave pulses (0.2 ms duration) at a frequency of 0.033 Hz and an intensity that triggered a 50% maximum response. LTP was induced using 200 Hz HFS (high-frequency stimulation) consisting of three sets of ten trains of 20 stimuli (inter-set intervals, 5 min). The stimulation intensity was not changed during HFS. The magnitude of LTP is expressed as the percentage of pre-HFS baseline EPSP amplitude (mean + − S.E.M.). One-way ANOVA was used to compare the magnitude of LTP for the last 10 min (i.e. at 3 h) post-HFS between multiple groups. Student's t test and Bonferroni's test were used for detailed statistical analysis where appropriate and P < 0.05 was considered statistically significant.
Analytical SEC
Samples (10 μl) were loaded on to a Superdex 75 3.2/300 PE column, eluted at 0.05 ml/min and the A 214 was recorded. For t 1/2max and t max , samples were first centrifuged at 16 000 g for 30 min to remove any insoluble aggregates.
QLS (quasi-elastic light scattering)
Samples were collected directly from a Superdex 75 10/300 column into a borosilicate glass test tube [31] and immediately analysed by QLS. Thereafter, samples were incubated at 4
• C for 2 h, then re-analysed by QLS and the analysis continued for a further 22 h. Measurements were made using a custom optical setup [32] comprising a 40 mW He-Ne laser (λ = 633 nm) (Coherent) and a PD4047 detector/correlator unit (Precision Detectors). Light scattering was measured at 90
• . The intensity correlation function and the distribution of the R H (hydrodynamic radii) of the particles contributing to the scattering were determined using Precision Deconvolve software (Precision Detectors).
CD
Samples at given time points were diluted to 100 μM monomer or 50 μM dimer and transferred to a 1 mm quartz cuvette (Starna Scientific). Spectra were recorded at 4
• C between 280 nm and 190 nm with 0.2 nm intervals and 20 nm/min continuous scanning using a J-185 CD spectropolarimeter (JASCO). Curves generated from the average of three accumulations were manipulated by subtracting the blank buffer signal and smoothened using a meansmovement function with a convolution width of 15 data points. Data are shown as mean molar ellipticity (θ ).
NMR spectroscopy
To obtain isotopically labelled Aβ(M1-40) and Aβ(M1-40)S26C, transformed bacteria were grown in M9 minimal medium containing 4 g/l D-[ 13 2 were dissolved in 0.5 ml of 7 M guanidine hydrochloride and incubated overnight at room temperature. Aβ monomers or dimers were isolated by SEC as described above, but eluted in 25 mM ammonium bicarbonate, pH 8.0. Peak fractions were collected and peptide concentration determined at A 275 or A 283 . Samples were diluted to ∼200 μM in an NMR tube containing 0.15 mM DSS (2,2-dimethyl-2-silapentane-5-sulfonic acid) and 10 % 2 H 2 O. All experiments were carried out on a Varian Unity INOVA 600 MHz spectrometer equipped with a pulsed field gradient probe at 278 K. Backbone 1 Hα, 13 Cα and 13 C' chemical shifts were assigned based on 2D-NMR experiments, such as ( 13 C, 1 H)-HSQC (aliphatic region), CO(CA)H, HA(CA)N, ( 15 N, 1 H)-HSQC, as well as 3D HNCO and HNCA. All spectra were processed using NMRPipe [34] and analysed using Sparky [35] (http://www.cgl.ucsf.edu/home/sparky/). Chemical shifts were referenced to DSS based on IUPAC recommendation [36] . Structural propensities of Aβ(M1-40), [Aβ(M1-40)] DiY and [Aβ(M1-40)S26C] 2 were calculated using ncSPC (neighbourcorrected structural propensity calculator) [37, 38] . Figure S4 ), but, in general, these appear more straight and rigid than protofibrils formed under quiescent conditions ( Figure 1B) . Given the dramatic difference in the aggregation propensities and ultrastructures of aggregates formed by the three different peptides, we were anxious to investigate the disease-relevant activity of aggregates formed by each peptide. Changes in the metabolism of Aβ occur 15-20 years in advance of overt symptoms of AD [40, 41] and long before detectable neuronal loss, and Aβ is postulated to chronically disrupt synaptic efficacy and episodic memory [42] . LTP is a cellular correlate of learning and memory that is exquisitely sensitive to disruption by Aβ [43] , consequently, we chose to determine the biological activity of [Aβ(1-40)] DiY by comparing its ability to inhibit LTP with that of Aβ . The precise assembly form(s) of Aβ that cause neuronal compromise in AD are, as yet, ill-defined [3, 7] . Thus rather than studying a single Aβ assembly, we collected peptide samples at defined time points along the aggregation reaction. In this way, we compared the synaptic plasticity disrupting activity of unaggregated and mixed aggregates of each peptide. For Aβ and [Aβ(1-40)] DiY , mixed aggregates were prepared using SEC to isolate peptides in 20 mM phosphate buffer, pH 8.0, and shaking the isolated material until they attained t1 / 2 max (Figures 2A and 2B ). Zero time (t = 0) and t1 / 2 max samples were flash frozen and stored at − 80
• C. Aliquots of these were then thawed immediately before biophysical or electrophysiology experiments. The most prominent assemblies present in the t1 Figure 2D ). In contrast, neither unaggregated Aβ(1-40) monomer nor [Aβ(1-40)] DiY alters LTP (160 pmol, 126.0 + − 3.0 %, n = 4, and 124.7 + − 2.6 %, n = 6, respectively, P > 0.05), with LTP being indistinguishable from that in the vehicle control ( Figure 2D ). In accordance with our previous study, [Aβ(1-40)S26C] 2 protofibrils at this dose also strongly inhibited LTP (114.3 + − 1.2 %, n = 7, P 0.05 compared with vehicle) [17] . The dose of 160 pmol of Aβ was chosen because it caused near-maximum inhibition of LTP ( Figure 2D ). the plasticity disrupting activity previously attributed to brainderived dimers [10, 16] is mediated not by the dimers, but by the higher assemblies the dimers form. It is intriguing that all three peptides form toxic assemblies, despite the distinct morphologies of their aggregates. In an effort to better understand the basis of the dramatically different aggregation kinetics and assembly forms that these peptides produced, we investigated the structures of the component monomers and dimers.
Recombinantly produced and chemically synthesized Aβ peptides have similar aggregation kinetics and products
The method of choice for high-resolution analysis of protein and peptide structure is NMR spectroscopy, a method which necessitates the use of isotopically labelled ( 13 C and 15 N) peptides. Recombinant 
Mild alkaline pH and low temperature prevents aggregation of Aβ(M1-40), [Aβ(M1-40)] DiY and [Aβ(M1-40)S26C] 2 and facilitates analysis of authentic monomer and dimers
Having assured ourselves that recombinant and synthetic peptides aggregate in a similar manner, we then proceeded to investigate conditions that would allow isolation and use of highly concentrated recombinant peptide samples, yet would preclude aggregation over the 2 h period required for NMR experiments. To achieve this, we used 25 mM ammonium bicarbonate buffer at pH 8.0. In order to simulate conditions to be used for NMR, we tested peptide samples collected into NMR tubes immediately after SEC isolation and again following 2 h of incubation at 4
• C. Analytical SEC indicated that even after 24 h monomer and dimers did not assemble further ( Figure 3A) . Although there were no indications of higher-molecular-mass species, it is possible that certain Aβ aggregates could stick to the column. To control for this possibility, we monitored the height and area of monomeric/dimeric peaks. Using this approach we could discern no change in the amount of Aβ(M1-40) monomer or [Aβ(M1-40)] DiY ( Figure 3A ). In contrast, there was a ∼4 % reduction in the amount of [Aβ(M1-40)S26C] 2 detected at 24 h compared with t = 0, but importantly, there was no reduction after 2 h ( Figure 3A , inset).
To complement our SEC analysis, we also used a solutionbased non-invasive technique, QLS, which revealed that SECisolated Aβ(M1-40) had a R H of ∼1.7 nm, whereas the R H for both [Aβ(M1-40)] DiY and [Aβ(M1-40)S26C] 2 was ∼2.2 nm ( Figure 3B, panel i) . These estimates are consistent with the expected size of Aβ monomer and dimers. Since the intensity of light scattered by a particle is proportional to its mass squared, and assuming at the least a linear dependence of the R H on the particle mass, we conservatively estimate that 99 % of Aβ(M1- We used NMR spectroscopy to search for local secondary structure differences that would not be detected by CD. A battery of NMR analyses ( (Figures 4C and 4D ). 13 C, 1 H cross-peak differences between the dimers and wild-type monomer are mainly located around the sites of covalent crosslinking ( Figures 4C and 4D ) and 13 Cα, 1 Hα cross-peak intensities are decreased in these regions (Supplementary Figure S8 13 Cα and 13 CO chemical shifts are extremely sensitive to secondary structure [46] , we first used these to gauge whether any changes in secondary structure might have resulted from covalent dimerization that could explain differences in aggregation kinetics and/or the types of aggregates formed. 13 C, barring a single exception). These results are in keeping with our CD analysis and indicate that no major overall structural conversions occurred (Figure 4 ). This fact notwithstanding, NMR chemical shift differences observed between the samples are significant, and also distinct for the two dimeric peptides. 13 Cα and 13 CO chemical shift changes, indicating an opposite trend in its inclination for secondary structure. In addition, these changes are observed on either side of the disulfide cross-link, and extend also further away, affecting the structural propensity of residues Leu 17 -Phe 20 and Leu 34 -Gly 37 ( Figures 5D-5F ).
To propensities to form an α-helix or β-strand at each position in the primary sequence. This is done by calculating the difference δ between the observed chemical shifts and those expected for 'random coil' values of the same polypeptide. For 1 Hα, positive values then signify β-sheet propensity, whereas negative shifts denote helical propensity. Analogously, for 13 Cα and 13 CO, negative values correspond to β-sheet propensity and positive differences equate to α-helix propensity [46] . In what follows, 'random coil' reference values are taken from a neighbourcorrected random coil chemical shift library for intrinsically disordered protein sequences [37, 38] .
Subsequently, the program ncSPC was used to predict adoption of canonical secondary structure conformations (i.e. α-helix or β-sheet) on a continuous scale from 0 to 1 [37, 38] . Using this approach, Aβ(M1-40) is predicted to contain two regions of helical propensity. The first involves a relatively long stretch between residues His 6 -Lys 16 and the second a short stretch between residues Gly 38 -Val 40 . But the strongest predicted feature indicates two backbone regions prone to forming β-sheet secondary structure, between residues Val 17 -Val 24 and Ala 30 -Met 35 ( Figure 6A ). These are the same regions known to form in an anti-parallel β-sheet when Aβ(1-40) is complexed with the single-chain affibody, ZAβ 3 [47] , and to participate in the intermolecular β-sheets formed by Aβ monomers stacked along the long axis of fibrils (reviewed in [48] ). The introduction of a covalent cross-link between tyrosine residues in [Aβ ] DiY yields a large increase in the predicted helical propensity between residues Glu 3 -Val 12 and a loss of helicity in the Cterminus involving residues Gly 38 Figure 5 Covalent cross-links in Aβ dimers cause small, but specific, changes to local and global 2D structures Chemical shift differences ( δ) observed for (A and D) 1 Hα, (B and E) 13 Cα and (C and F) 13 -40) ]. For 1 Hα, positive differences indicate increased β-sheet formation and/or reduced helical propensity, whereas negative differences denote the opposite. For 13 Cα and 13 CO spectra, the opposite is the case, positive differences indicate increased helical structure and reduced β-sheet formation, whereas negative shifts correspond to the opposite situation.
increases in predicted β-sheet propensity within residues Gln 15 -Gly 25 and Asn 27 -Ile 32 , and to a lesser extent Gly 38 -Val 40 (compare Figures 6A and 6C) . When analysed using ncSPC, the Aβ(1-40)-ZAβ3 complex reported by Hoyer et al. [47] (Supplementary Figure S9 at http://www.biochemj.org/bj/461/bj4610413add.htm) showed the involvement of the same residues in β-sheet propensity. Given this is a very stable complex, the predicted β-sheet propensity is extremely high. These results demonstrate that covalent cross-links between monomers have a modest, but detectable, influence on the secondary structure propensity of Aβ.
Overall, the [Aβ(M1-40)] DiY cross-linked peptide is associated with a slight increase in helicity throughout the Aβ molecule, 13 Cα, 1 Hα, 15 N and 13 C' backbone chemical shifts. The structural propensity for each chemical shift was calculated using ncSPC [38] . Positive values indicate helical propensity and negative values predict β-sheet conformation. Broken lines at 0.14 and − 0.14 are included for ease of comparison.
except at the extreme C-terminus, and this dimer aggregates very slowly forming long smooth fibrils. In contrast, the cystine crosslink produces a dimer that aggregates extremely rapidly, but only forms short fibrils. On basis of the collective data presented, it is apparent that rather modest differences in the secondary structure propensity have a drastic influence on the type and rate at which aggregates are formed.
DISCUSSION
Considerable evidence suggests that dimers of Aβ play an important role in AD [8, 10, 16, 28, [49] [50] [51] [52] , however, owing to the low abundance and difficulty in purifying native dimers, their structure and aggregation propensity have not been investigated. In Nature, there are few possible ways by which covalent dimers could be formed, the most likely of which involve the coupling of two Aβ monomers by a DiY bond, [Aβ] DiY . Thus we studied [Aβ] DiY , and for comparison, we also investigated the previously described design dimer, [AβS26C] 2 [17] . In their unaggregated state, [Aβ] DiY and [AβS26C] 2 lack appreciable structure and fail to alter LTP. However, both dimers self-associate to form larger structures and during the assembly process generate aggregates that potently block LTP. These data have important implications for our understanding of AD, in that contrary to previous assertions, dimers themselves are not directly toxic. Moreover, the lack of stable structure in the starting dimers indicates that differences in aggregation propensities of [Aβ] DiY and [AβS26C] 2 are not driven by fixed structures in these dimers, but by the population of structures that dimers can access, and by how well certain dimer structures can be accommodated into the quaternary structure of protofibrils and fibrils.
Recent work indicates that aggregation of Aβ monomer involves both primary and secondary nucleation [53, 54] , and that aggregation under agitated conditions is enhanced by breakage of fibrils to form new seeds [55] . Primary nucleation occurs first and involves only monomer. The nuclei thus formed grow quickly and fibrils appear. Thereafter fibrils provide a catalytic surface for nucleation from monomers, and secondary nucleation becomes faster than primary nucleation [53, 54] . Even at high concentrations [Aβ] DiY has a lag phase more than 20-fold as long and an aggregation rate ∼15-fold lower than found for equivalent concentrations of Aβ monomer. Thus the DiY crosslink seems to inhibit primary nucleation and subsequently retards fibril elongation and fibril-fibril interactions. lies in an unstructured region outside the β-hairpin found in the core of amyloid fibrils [56] [57] [58] , SDS-stabilized oligomers [59] or Aβ monomer complexed with the affibody, ZAβ 3 [47] . Our chemical shift analysis indicates that dimer formation at Tyr 10 leads to an overall increase in the helical propensity of residues Arg 5 -Gln 15 , but has little effect on β-sheet forming residues. Thus the slower kinetics and more regular fibrils formed by [Aβ] DiY may result not from differences in propensity to form β-sheets, but rather from differences in the type of β-sheets formed. For instance, the increased helicity in the N-terminus and the modest increase in β-sheet propensity of Gly 37 -Gly 38 could promote intermolecular parallel β-sheets favoured by mature fibrils [56] [57] [58] . In future studies, it will be important to use solid-state NMR to investigate the structure of [ 2 itself serves as a nucleus. In either case, the consequence is to retard fibril elongation and fibril-fibril interactions. This is in keeping with our previous report that [AβS26C] 2 forms kinetically trapped protofibrils [17] . Moreover, the enhancement of nucleation seen in [AβS26C] 2 relative to Aβ monomer is congruent with the subtle structural differences revealed by our comparison of chemical shift differences and suggest that [AβS26C] 2 's faster nucleation results from an increased propensity to form β-structure. In previous studies, intramolecular disulfide cross-links engineered to stabilize a two-stranded anti-parallel β-sheet produced an Aβ monomer (referred to as Aβcc) that readily formed protofibrils, but that was incapable of forming fibrils [60] . Since the disulfide link in [AβS26C] 2 is intermolecular and is positioned within the proposed bend/turn found in both amyloid fibrils [56] [57] [58] and Aβcc [47, 60] , the increased β-propensity of [AβS26C] 2 could lead to formation of either intramolecular anti-parallel β-sheets or intermolecular parallel β-sheets. Indeed, solution NMR studies of oligomers formed in the presence of SDS found both inter-and intra-molecular β-sheets [59] . Given the predicted increase in β-sheet propensity of residues Leu 17 -Gly 25 and Lys 28 -Val 39 , it is conceivable that [AβS26C] 2 assumes a conformation in protofibrils similar to that observed for dimer subunits in SDS-stabilized oligomers [59] . Conversion from this mixed antiparallel/parallel conformation into the topologically distinct β-hairpin characteristic of amyloid fibrils [56] [57] [58] might suffer from a higher energetic barrier and could explain why [AβS26C] 2 forms protofibrils, but not fibrils.
Thermodynamically, the formation of a particular aggregate structure depends on the free energy of competing structures, but high-kinetic barriers that slow down the formation of more stable aggregates, such as amyloid fibrils, also play an important role. Thus effects on fibril nucleation, elongation and/or fibril-fibril interactions could influence the kinetic stability of structures in at least two different ways: (i) accelerated nucleation could lead to more growing nuclei and therefore lower monomer concentration and hence shorter assemblies and (ii) physical instability could limit the length of certain structures. Both of these possibilities could explain the rapid appearance and long persistence of short protofibril-like structures formed by [AβS26C] 2 and the slow appearance and formation of the exceptionally long and ordered fibrils formed by [Aβ] DiY .
Although the structural propensity and aggregation of [AβS26C] 2 and [Aβ] DiY are quite different, they have a similar functional outcome in that they populate intermediate assemblies for an extended period. Importantly, the assemblies that are formed inhibit synaptic plasticity, this despite the fact that their aggregate intermediates have different morphologies. Thus these findings demonstrate that a range of structures can impair synaptic plasticity, and that the size and diffusibility of aggregates may be key to their synaptotoxic activity. Similarly, it is reasonable to expect that other conditions which enhance the population of certain assemblies, for instance subtle changes in the ratios of different alloforms of Aβ [61] , would lead to disease. In this regard, factors that control the 'lifetime' of synaptotoxic assemblies will be critical determinants of their toxic effect. Indeed, studies which have examined oligomerization, aggregation and toxicity of different ratios of Aβ42/Aβ40 indicate that toxicity is greatest for mixtures of Aβ40/Aβ42 that increase the lifetime of oligomeric assemblies [62, 63] . In the case of [Aβ] DiY , the slowed kinetics of aggregation would lead to a protracted period during which soluble synaptotoxic assemblies are present. Therefore what appear as very subtle changes in structural propensity could in fact have a dramatic and detrimental effect on cognition. Given that oxidative cross-linking of tyrosine residues represent the most likely way to form covalently linked Aβ dimers and that there is immuno-EM evidence of Aβ and DiY co-localizing in human specimens [22] , it will be important to search for soluble species of [Aβ] DiY in the brain and cerebrospinal fluid and to elucidate the mechanisms by which [Aβ] DiY is formed. Moreover, although we have focused on dimers formed from the most naturally abundant form of Aβ, Aβ(1-40), it will be important to extend these studies to include dimers built from the more disease-associated Aβ(1-42) [64] ; and to explore the important issues of heterodimers and different ratios of Aβ40 and Aβ42 dimers [65] . 
